Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo

Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells

(2015) Henry Ogbomo et al.   NEOPLASIA

NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors

(2012) Christopher A Alvarez-Breckenridge et al.   NATURE MEDICINE

TGF-  downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients

(2011) C. A. Crane et al.   NEURO-ONCOLOGY

Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy

(2011) Henry Ogbomo et al.   TRENDS IN MOLECULAR MEDICINE

Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin

(2010) X. Lun et al.   CANCER RESEARCH

Enhancement of NK cell antitumor responses using an oncolytic parvovirus

(2010) Rauf Bhat et al.   INTERNATIONAL JOURNAL OF CANCER

A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells

(2010) T. D. Holmes et al.   JOURNAL OF IMMUNOLOGY

Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions

(2010) Tony Avril et al.   JOURNAL OF NEUROIMMUNOLOGY

The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics

(2010) Jia Liu et al.   MICROBES AND INFECTION

NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties

(2009) R. Castriconi et al.   JOURNAL OF IMMUNOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells

(2009) Henry Ogbomo et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY